A crucial element in accelerating progress is the development of improved surveillance systems and tools that provide decision-makers with timely, high-quality data and actionable insights. The investments made to establish genomic platforms for COVID-19 surveillance have catalyzed a genomic revolution—one that can now be leveraged to strengthen the surveillance of endemic diseases such as malaria.